1-15 of 367
Early Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
DermatologyEarly Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
Once-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
DermatologyOnce-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
Unpacking the Complexity of Psoriatic Arthritis
Living RheumUnpacking the Complexity of Psoriatic Arthritis
Diagnosing Psoriatic Arthritis: A Real-World Case
Living RheumDiagnosing Psoriatic Arthritis: A Real-World Case
Modern Approaches to Psoriatic Arthritis Management
Living RheumModern Approaches to Psoriatic Arthritis Management
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
AudioAbstractsComparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
- advertisement
Practical Strategies for Improving Adherence in Psoriasis Care
On the Frontlines of PsoriasisPractical Strategies for Improving Adherence in Psoriasis Care
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Living RheumJAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Living RheumShared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Validating hf-PGA for Hand and Foot Psoriasis Severity in Adults
DermConsultValidating hf-PGA for Hand and Foot Psoriasis Severity in Adults
IL-17A Inhibition and Neuroendocrine Signaling in Psoriasis
DermConsultIL-17A Inhibition and Neuroendocrine Signaling in Psoriasis
- advertisement
IL-17A Inhibition and the Stress Response in Psoriasis
AudioAbstractsIL-17A Inhibition and the Stress Response in Psoriasis
Addressing Diagnostic Gaps in Psoriasis for Skin of Color
DermConsultAddressing Diagnostic Gaps in Psoriasis for Skin of Color
Rethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color
DermConsultRethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color
